INDIANAPOLIS, March 6, 2018 /PRNewswire/ -- Roche Diagnostics has been named one of the 2018 NAFE Top Companies for Executive Women by the National Association for Female Executives, to recognize American corporations where women have significant clout to make the decisions that affect their company's future and its bottom line. The NAFE Top 70 Companies, released today, is featured in April/May issue of Working Mother. The full report on this year's winners are listed here.
"It's an incredible honor to be recognized as an NAFE Top Company for Executive Women this close to International Women's Day," said Bridget Boyle, VP and Site Head, Human Resources, Roche Diagnostics. "We're very proud of the progress we've made over the last several years and we will continue to strive for even more representation of women at all levels of the company through additional training, mentoring and sponsorship opportunities."
Betty Spence, president of NAFE, says, "NAFE's annual scrutiny of women's progress at American companies offers essential data about the movement of women into top leadership in the private sector. In this first year of having five NAFE Top Companies with boards of 50 percent or more women, we point to a synergy between the greater presence of women on the board and an increase in the number of winning companies with women CEOs and with 50 percent-plus women in the C-suite (10 companies)."
Subha V. Barry, senior vice president & managing director, Working Mother Media, says, "NAFE's Top Companies shows us what progressive organizations are doing to ensure women's advancement into executive positions. This year, noting increased enrollment and more companies with high scores, we decided to enlarge the list by 10. Areas such as number of female CEOs and promotions at every level illustrate improvement. However, while there is increased CEO engagement in making sure women have the best chance to become leaders, we also note there has also been a dip in key indicators like top earners, which needs to be addressed."
About the Methodology
The 2018 NAFE Top Companies application includes some 200 questions on female representation at all levels, especially the corporate officer and profit-and-loss ranks. The vetting process includes tracking access and usage of programs and policies that promote the advancement of women as well as the training and accountability of managers in relation to the number of women who advance. In order to be eligible for the NAFE Top Companies survey, entrants must have a minimum of 1,000 employees, two women on the Board of Directors and be a public or private company. NAFE also separately names the Top 10 companies in the nonprofit sector.
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.
Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
All trademarks used or mentioned in this release are protected by law.
ABOUT NAFE
The National Association for Female Executives (NAFE), founded in 1972, serves 20,000 members nationwide with networking, tools and solutions to strengthen and grow their careers and businesses. Working Mother magazine publishes the annual NAFE Top Companies list. NAFE.com provides up-to-date information, a community for women in business, and access to member benefits. NAFE is a division of Working Mother Media, owned by the Bonnier Corporation.
Roche Contact: Amberly Peterson, amberly.peterson@roche.com, 317-270-8064
NAFE Contact: Andrea Kaplan, andreakaplanpr@gmail.com, 917-836-2741
View original content with multimedia:http://www.prnewswire.com/news-releases/nafe-names-roche-diagnostics-one-of-the-2018-top-70-companies-for-executive-women-300608263.html
SOURCE Roche Diagnostics
Share this article